si bone
-
Spine
SI-BONE Announces Publication of iMIA – a 2nd Multicenter Randomized Controlled Trial of the iFuse Implant System®
SAN JOSE, Calif., Sept. 25, 2017 /PRNewswire/ — SI-BONE, Inc., an innovative medical device company which pioneered the use of the iFuse Implant…
Read More » -
Spine
SI-BONE, Inc. Announces Highmark, Inc., 4th Largest BCBS Plan & 10th Largest Commerical Payor, Establishes Coverage Policy for MIS SI Joint Fusion IFuse Implant System
SAN JOSE, Calif., Aug. 23, 2017 /PRNewswire/ — SI-BONE, Inc., an innovative medical device company that pioneered the use of the iFuse…
Read More » -
Spine
SI-BONE, Inc. Announces Publication of a Level I Study Demonstrating Strong Clinical Prediction for the Diagnosis of SI Joint Dysfunction
SAN JOSE, Calif., Aug. 9, 2017 /PRNewswire/ — SI-BONE, Inc., an innovative medical device company that pioneered the use of the iFuse Implant…
Read More » -
Spine
SI-BONE, Minimally Invasive SI Joint Fusion using the iFuse Implant System® Maintains Exclusive Coverage with BCBS of IL, MT,NM,OK,TX
SAN JOSE, Calif., Aug. 2, 2017 /PRNewswire/ — SI-BONE, Inc., an innovative medical device company that pioneered the use of the iFuse…
Read More » -
Hospitals
SI-BONE Wins FDA Clearance and Full U.S. Commercial Launch of the iFuse-3D Implant
SAN JOSE, Calif., June 13, 2017 /PRNewswire/ — SI-BONE, Inc., an innovative medical device company that pioneered the use of the…
Read More » -
Spine
SI-BONE, Inc. Announces Blue Cross and Blue Shield of Vermont Establishes Positive Coverage Policy for MIS Sacroiliac Joint Fusion
SAN JOSE, Calif., June 12, 2017 /PRNewswire/ — SI-BONE, Inc., an innovative medical device company that pioneered the use of the…
Read More » -
Spine
SI-BONE – SI Joint Fusion Study Showed Patients Were 11X Less Likely to be Taking Opioids at Last Follow-Up Using the iFuse Implant™
SAN JOSE, Calif., May 1, 2017 /PRNewswire/ — SI-BONE, Inc., an innovative medical device company that pioneered the use of the…
Read More » -
Spine
SI-BONE, Inc. Announces Publication of 6-year Clinical Results Demonstrating Long-Term Positive Outcomes of iFuse Implant System®
SAN JOSE, Calif., April 24, 2017 /PRNewswire/ — SI-BONE, Inc., an innovative medical device company that pioneered the use of the…
Read More » -
Spine
SI-BONE, Inc. Announces Published Guidance Recommendation for Minimally Invasive SI Joint Fusion from NICE
SAN JOSE, Calif., April 7, 2017 — SI-BONE, Inc., an innovative medical device company that pioneered the use of the…
Read More » -
Spine
SI-BONE, Inc. Announces 50th Peer-Reviewed Publication for the iFuse Implant System® and 25,000th iFuse Procedure
SAN JOSE, Calif., April 3, 2017 /PRNewswire/ — SI-BONE, Inc., an innovative medical device company that pioneered the use of the…
Read More » -
Spine
SI-BONE’s iFuse Implant System® Requires Revision Surgery 5 Times Less Compared to SI Joint Fixation with Screws According to New Peer-Reviewed Clinical Publication
SAN JOSE, Calif., Jan. 23, 2017 /PRNewswire/ — SI-BONE, Inc., an innovative medical device company that pioneered the use of the iFuse…
Read More » -
Spine
SI-BONE, Inc. Announces iFuse Implant System® Warranty Program in Support of Patients, Providers and Payors
SAN JOSE, Calif., Jan. 9, 2017 /PRNewswire/ — SI-BONE, Inc., an innovative medical device company that pioneered the use of the iFuse Implant…
Read More » -
Financial
SI-BONE, Inc. Announces SelectHealth of Utah to Cover Minimally Invasive Sacroiliac Joint Fusion Exclusively Using the iFuse Implant System® as the Only Proven Technology
SAN JOSE, Calif., Oct. 27, 2016 /PRNewswire/ — SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System…
Read More » -
Spine
SI-BONE, Inc. Continues Leadership in Clinical Evidence Transparency Initiative Adding INSITE 2-Year RCT Results to Yale University Open Data Access Program
SAN JOSE, Calif., Oct. 5, 2016 /PRNewswire/ — SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System® (“iFuse”),…
Read More » -
Spine
SI-BONE, Inc. Announces Two-Year Results from a Randomized Controlled Trial of the iFuse Implant System® vs. Non-Surgical Management for Some Causes of Sacroiliac Joint Dysfunction
SAN JOSE, Calif., Aug. 24, 2016 /PRNewswire/ — SI-BONE, Inc., a medical device company that pioneered the use of the iFuse…
Read More »